Making better drugs for children with cancer
By: Committee on Shortening the Time Line for New Cancer Treatments, National Cancer Policy Board ; Peter C. Adamson ... [et al.], editors ; Institute of Medicine and National Research Council of the National Academies.
Contributors: Adamson, Peter C.; National Cancer Policy Board (U.S.). Committee on Shortening the Time Line for New Cancer Treatments.; Institute of Medicine (U.S.); National Research Council (U.S.); National Academy of Sciences (U.S.)
Publisher: National Academies Press
Published: 2005
Place of publication: Washington, D.C
Language: eng
Number of pages: 42
Subjects: Drug approval -- United States.; Cancer in children -- United States.; Neoplasms -- drug therapy -- Child -- United States.; Antineoplastic Agents -- Child -- United States.; Clinical Trials -- United States.; Drug Approval -- United States.; Neoplasms -- epidemiology -- Child -- United States.
Notes: Includes bibliographical references (p. 41-42).
Includes bibliographical references (p. 41-42).
Also available via the World Wide Web.
Table of contents: title: Childhood cancers: Background; title: Agents in use and in testing for children with cancer; title: The existing capacity for developing new agents specifically for childhood cancers; title: Putting the pieces together; title: Delays in testing approved agents in children; title: The need to prioritize agents for testing in children with cancer; title: Testing and labeling of drugs for pediatric use.